Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Celecoxib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 64Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PridCor Therapeutics Reveals Successful Long COVID Case Series
    PridCor Therapeutics Reveals Successful Long COVID Case Series

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144735/0/en/PridCor-Therapeutics-Reports-Positive-Long-COVID-Case-Series-with-Combination-Antiviral-Regimen.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Zydus Gets USFDA Approval for Celecoxib Capsules
    Zydus Gets USFDA Approval for Celecoxib Capsules

    15 Jul 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/zydus-receives-final-approval-from-usfda-for-celecoxib-capsules-17419

    INDPHARMAPOST
    15 Jul 2025
    Share Share
    Zydus`s Generics Celecoxib Receives Approval in US
    Zydus`s Generics Celecoxib Receives Approval in US

    14 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205938

    FDA
    14 Jul 2025
    Share Share
    Enforcement Report - Week of June 18, 2025
    Enforcement Report - Week of June 18, 2025

    18 Jun 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-18-2025-14246.pdf

    FDA
    18 Jun 2025
    Share Share
    Strides Pharma gets USFDA approval for Celecoxib Capsules
    Strides Pharma gets USFDA approval for Celecoxib Capsules

    01 May 2025

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2025/StridesSEIntimation_30_Apr_2025.pdf

    PRESS RELEASE
    01 May 2025
    Share Share
    Scilex Holding: New Drug ELYXYB® Approved for Migraine in Canada
    Scilex Holding: New Drug ELYXYB® Approved for Migraine in Canada

    15 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/15/3061807/0/en/Scilex-Holding-Company-Announces-Approval-of-a-New-Drug-Submission-NDS-from-the-Health-Canada-s-Pharmaceutical-Drugs-Directorate-Bureau-of-Cardiology-Allergy-and-Neurological-Scien.html

    GLOBENEWSWIRE
    15 Apr 2025
    Share Share